Dawn Sim

Medical Retina and Cataract Consultant at Moorfields Eye Hospital, London, UK

Sim is a consultant ophthalmic surgeon in the medical retina service at Moorfields Eye Hospital, and a former chief resident and current clinical lead for diabetic screening there. She has a PhD from the UCL Institute of Ophthalmology for her work on endothelial progenitor cells in retinal vascular diseases and has published extensively on diabetic macular ischemia. She also has a special interest in the area of virtual clinics and teleophthalmology and is working on device-agnostic platforms to facilitate acceleration of new technology into clinical practice. An ARVO Alcon Early Career Research Award winner, Dawn is a patent holder for the use of Indocyanine Green Dye for visualization of inflammation. A prolific and successful grant-raiser, Dawn also won the Dermot Pierse prize in 2009 and the 2009 Young Investigator’s Award at Asia ARVO
in 2007.

One nominator said: “Dawn is a great surgeon and a superb researcher. Her diabetic retinopathy screening work is some of the best in the world.”

Part of the Power List 2017

Thanks to the demographics of the developed world, the future of eyecare looks like it will be one of limited resources and rising patient burden.

So who will lead ophthalmology over the next few decades and shape its future? To find out, we asked you, our readers, to vote for ophthalmology’s Top 50 rising stars… and here they are.

Welcome to the 2017 Power List.

In 2018, The Ophthalmologist will be recognising the Top 100 pioneers and game-changers in the field of ophthalmology.

Go to The Power List 2017